跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
择思达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Atomoxetine Hydrochloride Capsules
Approved
化学药品
Atomoxetine Hydrochloride Capsules
LILLY SA
🇨🇳 National Medical Products Administration
Approval Date
Aug 13, 2020
Approval ID
888qHE7Ck5p
Company
LILLY SA
Type
化学药品
Approval Details
Approval Id
888qHE7Ck5p
Approval Number
国药准字HJ20160118
Generic Name
盐酸托莫西汀胶囊
Generic Name En
Atomoxetine Hydrochloride Capsules
Trade Name
择思达
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
40mg
Reg Date
2020-08-13
Expired Date
2025-08-12
Company Name
LILLY SA
Company Address
Avda.de la Industria,30 28108 ALCOBENDAS(MADRID),SPAIN
Production Company Name
lilly del caribe inc
Production Company Address
Puerto Rico Industrial Park,12.6 km-65th Infantry Road Carolina PR 00985 PUERTO RICO
Company Detail Path
/organization/lilly-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 13, 2020
Approval ID
888qHE7Ck5p
Type
化学药品
Back to NMPA Approvals